Skip to main content

Table 3 Treatment responses at day 28 after PCR correction for the first episode in the per- protocol patient populationa

From: Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

Treatment response

ASAQ

AL

Total

 

Number (%)

Overall population

(n = 183)

(n = 181)

(n = 364)

   Late clinical failure

0 (0)

3 (1.7)

3 (0.6)

   Late parasitological failure

1 (0.5)

2 (1.1)

3 (0.8)

   Adequate clinical and parasitological response

181 (98.9)

175 (98.7)

356 (97.8)

   Not applicable

1 (0.5)

1 (0.6)

2 (0.5)

<12 years old

(n = 100)

(n = 100)

(n = 200)

   Late clinical failure

0 (0.0)

3 (3.0)

3 (1.5)

   Late parasitological failure

1 (1.0)

1 (1.0)

2 (1.0)

   Adequate clinical and parasitological response

98 (98.0)

95 (95.0)

193 (96.5)

   Not applicable

1 (1.0)

1 (1.0)

2 (1.0)

12 years old

(n = 83)

(n = 82)

(n = 164)

   Late parasitological failure

0 (0.0)

1 (1.2)

1 (0.6)

   Adequate clinical and parasitological response

83 (100.0)

80 (97.6)

163 (99.8)

  1. aAll patients who completed the study protocol without any major protocol deviation in treatment evaluation.